The Federal Government of Nigeria has signed two significant letters of intent with Siemens Healthineers, its Nigerian partner Tanit Medical Engineering, and Abbott Laboratories GmbH to improve healthcare access and capacity across the country.
The agreements were signed by Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), with Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare, in attendance.
READ ALSO:Osun govt. to enhance healthcare delivery – Commissioner reveals
These partnerships aim to enhance the local assembly of ultrasound systems, improve medical training for Nigerian healthcare professionals, and ensure access to high-quality diagnostic solutions locally produced within Nigeria.
Professor Pate commended Dr. Mukhtar and his team for their efforts in attracting global investment to the Nigerian health sector. He also highlighted the Executive Order providing incentives for investors in healthcare.
Dr. Mukhtar emphasized that the agreement reflects PVAC’s dedication to reducing import dependency and boosting local production of medical devices. “This MoU embodies our shared vision for advancing healthcare, enhancing access, and unlocking the potential of Nigeria’s healthcare value chain,” he stated.
The Memorandum of Understanding reaffirms the Federal Government’s commitment to advancing healthcare delivery through strategic public-private partnerships. “The initiative is expected to strengthen Nigeria’s self-sufficiency in diagnostic solutions while encouraging local innovation”.
The Vice President of Public Sector Engagement for Siemens Healthineers in the Middle East and Africa Dr. Kevin Massoudi, expressed the company’s dedication to advancing diagnostic services in Nigeria. He also praised Nigeria’s leadership in health innovation across the continent.
Similarly, Dr. Rabah El Menshawy of Abbott Laboratories commended the government’s forward-thinking leadership under President Bola Ahmed Tinubu. He described the MoU as a milestone that ensures access to high-quality diagnostics produced locally in Nigeria.
Dr. El Menshawy added that Abbott’s collaboration aligns with Nigeria’s goal of ending HIV infections by 2030. “The company’s commitment to promoting health equity includes creating job opportunities, building capacity, and transferring knowledge to Nigerians”.
The partnerships not only seek to improve healthcare delivery but also aim to bolster Nigeria’s economy. Local production of diagnostic tools is expected to generate employment and stimulate economic growth within the health sector.
Through these collaborations, Nigeria takes a significant step toward a sustainable and innovative healthcare system that meets the needs of its population while positioning the country as a leader in Africa’s health sector transformation.
Comments are closed.